Frontiers in Oncology

Systematic Review

Accepted on 28 Apr 2025

Cumulative temporal association between assisted reproductive technology and childhood cancer: a systematic review and meta-analysis of observational studies

Yanjie Jiang
Shipeng Zhang
Hanyu Wang
Xingyi He
Rui Fu
Junwen Tan
Qinwei Fu
Qinxiu Zhang
Yan Lu

Frontiers in Oncology

doi 10.3389/fonc.2025.1555420

Systematic Review

Accepted on 28 Apr 2025

Long-term outcomes in patients with endometrial cancer after sentinel lymph node biopsy versus lymphadenectomy alone: a meta-analysis

Sai Zhang
Juan Zheng
Dandan Zhu

Frontiers in Oncology

doi 10.3389/fonc.2025.1584447

Original Research

Accepted on 28 Apr 2025

Molecular targets and mechanisms of cortex mori for lung cancer treatment: A network pharmacology study, molecular docking and in vitro and in vivo experimental validation

Ying-Ying Shao
Qiuhong Yang
Shu-Fen He
Han-Bin Zhang
Weichao Han
Baocheng Xie
Ruirong He

Frontiers in Oncology

doi 10.3389/fonc.2025.1587856

Original Research

Accepted on 28 Apr 2025

The prognostic impact of Surufatinib for the treatment of advanced pancreatic ductal adenocarcinoma: A single center real-world retrospective study

Yanzhen Yang
Qu Xie
Chuankai Shang
Lai Jiang
Guojun Ding
DAN LONG
Cong Luo

Frontiers in Oncology

doi 10.3389/fonc.2025.1574934

Original Research

Accepted on 28 Apr 2025

tRF-1:28-Val-CAC-2 promotes the development of nasopharyngeal cancer by targeting EPHB2

Hui Li
Xiaomin Wang
Anchi Sun
Weiwei Liu
Rongrong Lv
Mingjie Zhang
Zhiwei Xing
Shiyin Ma
Yehai Liu
Kai Zhang

Frontiers in Oncology

doi 10.3389/fonc.2025.1564601

Original Research

Accepted on 28 Apr 2025

Intratumoral CD8+ tumor-infiltrating lymphocytes as prognostic predictors in radio-chemoradiotherapy-treated nasopharyngeal carcinoma

Xinjing Li
Xiaoming Qiu
Cuihong Lin
Yuanying Liu
Yongbin Wang
Langlang Tang
Yuanhe Tong
Linbo Tang

Frontiers in Oncology

doi 10.3389/fonc.2025.1551980

Original Research

Accepted on 28 Apr 2025

METTL3-mediated SNHG1 m 6 A modification promotes proliferation and migration by transcriptional regulation of WDR74 in osteosarcoma

Guanzhen Qiu
Yuxin Bao
Yuanzhuang Zhang
Yeqiu Xu
Tianhua Qiao
Chenghao Li
Hanjie Zhai
Zhenjun Chen
Fu Ren
Yong Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1529657

Case Report

Accepted on 28 Apr 2025

Surufatinib related nephrotic syndrome in a pancreatic neuroendocrine tumor: a case report and review of literature

Chengqian Shi
Jinglian Lin
Xiadan Xiang
Wenlong Bao
Jie Yang

Frontiers in Oncology

doi 10.3389/fonc.2025.1546217

Original Research

Accepted on 28 Apr 2025

Second-Line Chemotherapy Rechallenge in Lung Cancer Patients: A Moroccan Real-World Study

Hassan Abdelilah Tafenzi
Farah Choulli
Ismail Essaadi
Rhizlane Belbaraka

Frontiers in Oncology

doi 10.3389/fonc.2025.1489327

Review

Accepted on 28 Apr 2025

Feasibility of Elective Neck Irradiation in Treating Node-Negative Nasopharyngeal Carcinoma Patients: A Meta-Analysis

Jianfeng Zhou
Hongyong Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1456724

Correction

Accepted on 28 Apr 2025

Corrigendum: Development and Validation of Nomogram Models for Predicting Immune-Related Adverse Events in Recurrent and Metastatic Nasopharyngeal Carcinoma Patients Treated with PD-L1 Inhibitors

Mengyuan Liu
Zheran Liu
Shuangshuang He
Yiyan Pei
Shihong Xu
Junyou Ge
Yan Qing
Youneng Wei
Ye Chen
Ping Ai

Frontiers in Oncology

doi 10.3389/fonc.2025.1610079

Case Report

Accepted on 28 Apr 2025

Synchronous childhood T-lymphoblastic lymphoma and B-cell precursor acute lymphoblastic leukemia associated with constitutional MMR deficiency syndrome –a case report

Joanna Bulsa
Agata Karolina Pastorczak
Joanna Taha
Wojciech Mlynarski
Łukasz Sędek
Tomasz Szczepanski

Frontiers in Oncology

doi 10.3389/fonc.2025.1580494

Original Research

Accepted on 28 Apr 2025

Engineered Celastrol Liposomes with Glycyrrhizic Acid Augment Synergistic Antitumor Efficacy in Breast Cancer

Wei Zhang
Jiping Li
xiuli gao
Likun Liu
hong liang
Liling Yue

Frontiers in Oncology

doi 10.3389/fonc.2025.1602585

Original Research

Accepted on 28 Apr 2025

Antiproliferative and Pro-Apoptotic Effects of Pseudevernia furfuracea (L.) Zopf Extract and Its Active Component Physodic Acid via Oxidative Stress and DNA Damage in Breast Cancer Cells

Dominika Sebova
Simona Zilakova
Viktoria Medvecova
Michal Goga
Richard Frenak
Annamaria Bardelcikova
Andrej Mirossay
Ladislav Mirossay
Ján Mojžiš
Martin Kello

Frontiers in Oncology

doi 10.3389/fonc.2025.1557884

Editorial

Accepted on 28 Apr 2025

Editorial: Integrating Cervical Cancer Screening and Precancer Treatments

Noleb Mugisha
Leeya F Pinder
Manoj Menon

Frontiers in Oncology

doi 10.3389/fonc.2025.1614832

Original Research

Accepted on 28 Apr 2025

Cyclophosphamide for anticancer therapy-induced interstitial lung disease in the modern era: a retrospective cohort study

Honami Katahara
Kaede Baba
Hiromichi Nakajima
Chikako Funasaka
Chihiro Kondoh
Yoichi Naito
Hibiki Udagawa
Kohei Shitara
Tomoaki Sasaki
Toshikatsu Kawasaki

Frontiers in Oncology

doi 10.3389/fonc.2025.1567317